All News

Socioeconomic Gaps Can Lead to Poorer Outcomes in Multiple Myeloma

March 9th 2022

Although multiple myeloma survival rates have improved over the past 20 years, the survival gap among socioeconomic groups has widened.

Novel Advancements Have Led to More Tailored Treatments of Brain Metastases in HER2-Positive Metastatic Breast Cancer

March 9th 2022

Over the past several years, multiple treatment advancements have given oncologists the ability to better target brain metastases in patients with HER2-positive metastatic breast cancer.

‘Majority of Patients’ With Cholangiocarcinoma Still Receive Upfront Standard of Care Despite Recent FDA Drug Approvals

March 8th 2022

Despite several FDA drug approvals over the past few years in the cholangiocarcinoma space, many patients are ineligible for these treatments as a first option, signaling a significant unmet need.

Personalized Breast Cancer Treatments ‘Allows Us to Start With a Less Toxic Therapy’

March 8th 2022

When early-stage breast cancer regimens are based on an individual patient’s risk, there may be an opportunity to improve outcomes while mitigating severe side effects, too.

How I Get Through Cancer Survivorship When the Dark Days Take Over

March 8th 2022

While a recent health scare ruined a family vacation, I vowed to keep making plans and always look ahead to brighter days.

Body Image After Breast Cancer: Regaining Confidence Takes Time

March 8th 2022

Sara Montiel shares her experience and how time helped her find the confidence she needed for herself and her young daughter

A Look at Ototoxicity and Other Issues in Cancer Survivorship

March 8th 2022

From ototoxicity to body image issues after cancer, here's a look at the most recent issue of Heal®.

Keytruda Lengthens Time Until Distant Metastases Appear in Patients With Melanoma

March 7th 2022

The time patients with resected melanoma, a type of skin cancer, lived without their disease spreading to distant organs improved drastically after treatment with Keytruda.

Addressing Psychosocial Needs in Cancer Care Has Improved Over Past 20 Years, But More Work Still Needed

March 7th 2022

Increased resources and technological advances have allowed cancer survivors experiencing psychological side effects to seek help that might not have been available to them 20 years ago.

Can Reading Erotica Keep My Sexual Flame Burning After a Cancer Diagnosis?

March 7th 2022

Cancer took a toll on mine and my husband’s sex life, but after a great sexual encounter on New Year’s Eve, I wondered if adding erotica into our relationship might help keep that passion alive.

PSMA-Targeted Treatment Improves Bone-Related Pain in Metastatic, Castration-Resistant Prostate Cancer

March 7th 2022

Patients treated with Lutetium-177 PSMA-617 tended to experience improvements in quality of life related to the aches and pains that can come from bone metastases.

Novel Monoclonal Antibody Injection May Address Significant Unmet Need in Patients With Rare Tumor

March 7th 2022

As surgery is the current standard of care for patients with tenosynovial giant cell tumor, the potential to add another treatment option with fewer complications may dramatically help patients with this rare tumor.

Why I Advocate During Lymphedema Awareness Month

March 6th 2022

I was frustrated when I developed lymphedema after my 2014 breast cancer surgery, but have since turned those negative feelings into advocacy for others who may be affected by the condition, too.

FDA Approves Opdivo-Chemotherapy Regimen for Pre-Surgical Treatment of Non-Small Cell Lung Cancer

March 5th 2022

The FDA’s approval of the Opdivo plus platinum-doublet chemotherapy regimen marks the agency’s first greenlight, according to manufacturer Bristol Myers Squibb, of an immunotherapy-based treatment in the pre-surgical setting for non-small cell lung cancer.

Passion and Persistence in the Face of Metastatic Breast Cancer

March 5th 2022

The metastatic breast cancer community is a unique, strong-willed group of people who were honored in our inaugural Metastatic Breast Cancer HeroesTM program.

Newer and Unconventional Treatment Methods May Better Manage Breast Cancer Side Effects in the Future

March 4th 2022

From the use of anti-depressants to cryotherapy, researchers continue to explore potential ways to mitigate the side effects that are associated with breast cancer therapy.

Patient Enrollment Begins for Trial Assessing Novel Treatment Combo in Pancreatic Cancer

March 4th 2022

The study authors plan to enroll 32 patients with advanced pancreatic cancer into the trial to assess the efficacy and safety of an experimental treatment combination.

There Must Be a Cause for My Daughter’s Cancer, Right?

March 4th 2022

As humans, we have an inherent need to know why everything happens in our life — including a cancer diagnosis. But unfortunately, that is not always the case.

‘Jeopardy!’ Champ Ditches Wig to Make Statement About Her Cancer, Children in Ukraine Evacuated to Neighboring Countries to Continue Cancer Treatment and More

March 4th 2022

From a “Jeopardy!” winner taking her wig off on the gameshow to childhood patients with cancer in Ukraine being bussed to neighboring countries to safely receive treatment, here’s what’s happening in the cancer space this week.

Staying Aware With Self-Checks After Surviving Testicular Cancer

March 4th 2022

During his college years, Matt Froestad received the diagnosis not once but twice following self-exams.

An Oncologist Steps ‘Further Into the Cancer World’ After Breast Cancer Diagnosis

March 3rd 2022

The most revealing thing that Dr. Bhuvaneswari Ramaswamy, a breast medical oncologist, learned during her own treatment for breast cancer was that despite having extraordinary family and medical support, she still felt very isolated.

Listen Up: Hearing Loss Among Cancer Survivors Often Overlooked and Understudied

March 3rd 2022

Significant challenges include improving detection and response to inner ear side effects among cancer survivors following the use of certain drugs and therapies.

3 Stages of Coping With Cancer: There Are Better Days Ahead

March 3rd 2022

When I was first diagnosed with a stage 4 neuroendocrine tumor in my small intestine, I went through three stages of coping with my cancer: anger, planning and living life.

On Kidney Cancer Advocacy: ‘There’s Only One Way to Go, and That’s Forward’

March 3rd 2022

If an oncologist was apprehensive about Steven Edwards getting a second opinion, that might not be the right doctor for him, the kidney cancer survivor said.

Advocate Emphasizes ‘Investing in Yourself’ to Improve Patient-Physician Communication

March 3rd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about improving patient-physician communication throughout myeloma care.

Long-Term Care of Myeloma May Not Be ‘One-Stop-Shop,’ Multidisciplinary Approach Can Help

March 3rd 2022

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps, about treating myeloma as a chronic disease and how the multidisciplinary approach to care can assist in challenges, like financial toxicity.

CAR-T Cell Therapies Provide Patients With Mantle Cell and Follicular Lymphoma a ‘One and Done’ Treatment Option, Expert Says

March 2nd 2022

CAR-T cell therapies offer patients with lymphoma a chance for long-term remission, but none have yet to receive a greenlight from the FDA as a first line of treatment.

Leptomeningeal Disease: A Rare Cancer Metastasis

March 2nd 2022

The number of people developing leptomeningeal disease is increasing for the same reason that diagnoses of brain metastases are on the rise: People are living longer, giving cancer more time to spread.

I’m Trying to Balance My Fears of COVID-19 With Returning to Routine Cancer Screenings and Health Care

March 2nd 2022

I’ve recently joined the masses in catching up with routine health care that was put off during the COVID-19 pandemic.

More Effective, Less Toxic Treatment Approach for Brain Metastases May Improve Care and Survival

March 2nd 2022

Guidelines for the treatment of patients with brain metastases is moving from whole brain radiation therapy to less toxic treatment options to potentially improve care and increase survival.